Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Agouron Pharmaceuticals LLC
Original Assignee
Steven Lee Bender
Chris Allen Broka
Jeffrey Allen Campbell
Arlindo Lucas Castelhano
Robert Than Hendricks
Keshab Sarma
Lawrence Emerson Fisher
F. Hoffmann-La Roche Ag
Agouron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steven Lee Bender, Chris Allen Broka, Jeffrey Allen Campbell, Arlindo Lucas Castelhano, Robert Than Hendricks, Keshab Sarma, Lawrence Emerson Fisher, F. Hoffmann-La Roche Ag, Agouron Pharmaceuticals, Inc.filedCriticalSteven Lee Bender
Publication of CA2193178A1publicationCriticalpatent/CA2193178A1/fr
Application grantedgrantedCritical
Publication of CA2193178CpublicationCriticalpatent/CA2193178C/fr
3-aminoalkylamino- 2h-1,4-benzoxazines et 3-aminoalkylamino- 2h-1,4-benzothiazines constituant des ligands specifiques d'un sous-type de recepteur de la dopamine